SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 546 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,285,019 | -70.6% | 34,339 | -73.3% | 0.00% | -75.0% |
| Q2 2023 | $24,780,187 | +71.6% | 128,755 | +80.6% | 0.01% | +33.3% |
| Q1 2023 | $14,438,540 | +39.0% | 71,312 | -11.8% | 0.01% | +20.0% |
| Q4 2022 | $10,385,793 | -47.5% | 80,817 | -44.1% | 0.01% | -44.4% |
| Q3 2022 | $19,789,000 | +9.4% | 144,622 | +41.5% | 0.01% | +12.5% |
| Q2 2022 | $18,081,000 | -46.7% | 102,186 | -56.6% | 0.01% | -27.3% |
| Q1 2022 | $33,904,000 | -11.2% | 235,362 | -4.6% | 0.01% | -8.3% |
| Q4 2021 | $38,159,000 | +38.9% | 246,821 | +52.6% | 0.01% | +20.0% |
| Q3 2021 | $27,464,000 | +9.8% | 161,738 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $25,023,000 | +93.4% | 158,499 | +70.1% | 0.01% | +66.7% |
| Q1 2021 | $12,939,000 | -67.4% | 93,178 | -58.9% | 0.01% | -70.0% |
| Q4 2020 | $39,747,000 | – | 226,940 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |